Incyte Corporation (INCY) Social Stream

Incyte Corporation (INCY): $74.76

-0.02 (-0.03%)

POWR Rating

Component Grades













Add INCY to Watchlist
Sign Up

Industry: Biotech


of 461

in industry

Incyte Corp (INCY) Price Targets From Analysts

Use the tables below to see what analysts covering Incyte Corp think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
15 $109 $66 $88.416 $73.3 20.62%
14 $109 $66 $89.636 $73.3 22.29%
15 $109 $66 $89.636 $73.3 22.29%

The Trend in the Analyst Price Target

Over the past 18 months, INCY's average price target has gone down $12.64.

INCY reports an average of 28.94% for its upside potential over the past 18 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-19 15 109 66 88.416 64.51 37.06%
2020-05-18 21 121 79 101.060 NA NA%

INCY Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.93 8 0 7 0 0 15

The Trend in the Broker Recommendations

INCY's average broker recommendation rating improved by 0.21 over the prior 13 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for INCY as an investment opportunity.

  • The number of analysts covering the stock of INCY is greater than 261.76% of all US stocks.
  • INCY has a greater average analyst price target than 242.81% of Healthcare stocks.
  • The upside potential (average analyst target price relative to current price) of INCY is higher than 59.79% of Healthcare stocks.
  • INCY has a less variance in analysts' estimates than -104.41% of all US stocks.

Stocks similar to Incyte Corp in the Business Services industry regarding analyst recommendations and price targets are URI, CFLT and ZEN.

Is INCY a Buy, Hold or Sell? See the POWR Ratings now!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.0945 seconds.